Search results
The Zacks Analyst Blog Highlights Moderna, RAPT Therapeutics, Iovance, Sarepta Therapeutics and...
Zacks via Yahoo Finance· 4 months agoFor Immediate Release Chicago, IL – February 23, 2024 – Zacks.com announces the list of stocks...
Moderna (MRNA) to Report Q1 Earnings: Will It Beat Estimates?
Zacks via Yahoo Finance· 1 year agoWe expect Moderna MRNA to beat expectations when it reports first-quarter 2023 results on May 4,...
Should You Buy Moderna Before May 12?
Motley Fool via Yahoo Finance· 2 months agoModerna (NASDAQ: MRNA) stock soared earlier in the pandemic as the company developed its coronavirus vaccine and the product went on to generate billions...
Arcturus' (ARCT) CF Drug Gets FDA's Orphan Status, Stock Up
Zacks via Yahoo Finance· 7 months agoArcturus Therapeutics Holdings Inc. ARCT announced that the FDA has granted the Orphan Drug...
Novavax, With A 369% Gain, Reverses Bullish Gains After Key FDA Move
Investor's Business Daily· 2 weeks agoNovavax stock zipped higher Thursday — and then gave it all up — after the Food and Drug...
Is Moderna Building a Respiratory Vaccine Empire?
Motley Fool· 1 year agoModerna (NASDAQ: MRNA) made a name for itself through its coronavirus vaccine. The vaccine has generated billions of dollars in earnings over the past...
Biotech Stock Roundup: MRNAs Pipeline News, RCKT, BCYC Rally on Study Updates
Zacks via Yahoo Finance· 9 months agoIt was a busy week for the biotech sector, with quite a few important regulatory and pipeline...
Biotech Stock Roundup: PRAX, VKTX Up on Study Results & MRNA, REGN Give Updates
Zacks via Yahoo Finance· 3 months agoIt was a busy week for the biotech sector, with lots of study data readouts and regulatory updates....
The new COVID booster shots are in Rhode Island. What to know and how to get one
The Providence Journal via Yahoo News· 2 years agoA new type of COVID-19 booster shot received approval last week from the Food and Drug...
Ready to Buy the Dip? This Biotech Stock Is a Smart Buy
Motley Fool· 1 year agoModerna (NASDAQ: MRNA) saw its shares jump in 2021 and 2022 on the back of strong sales of its...